Biotech Pharmacon to trial SBG/Rituxan combination therapy with Radium
Latest beta-glucan/cancer antibody study follows Herceptin
06-Dec-2005 -
Biotec Pharmacon and the Norwegian Rikshospitalet - Radiumhospitalet TRUST (Department for Clinical Cancer Research) have signed a Letter of Intent to perform clinical studies to evaluate the efficacy and safety of the company's pharmaceutical compound SBG in combination with cancer antibodies in ...
antibodies
clinical trials
lymphoma
+3